Literature DB >> 12676806

Role of repeated lung injury and genetic background in bleomycin-induced fibrosis.

Man Pyo Chung1, Martha M Monick, Nabeel Y Hamzeh, Noah S Butler, Linda S Powers, Gary W Hunninghake.   

Abstract

Current hypotheses of the pathogenesis of many forms of pulmonary fibrosis suggest that (i) a stimulus results in repeated or prolonged episodes of lung injury, and (ii) genetic factors modulate the outcome of the injury. The commonly employed single-exposure bleomycin model results in only temporary fibrosis. Therefore, we evaluated whether repeated bleomycin exposures, in the setting of a genetic background more likely to develop a T helper 2 (Th2) response, would induce prolonged fibrosis. Lung fibrosis was induced by intratracheal bleomycin injection, either as a single exposure or as three consecutive exposures. We found that bleomycin induced a Th2-like environment in both Th1-biased C57BL/6J and Th2-biased DBA/2 mice. We also found histologic changes and collagen increases consistent with lung injury/fibrosis at early time points, but prolonged fibrosis only after multiple exposures in the Th2-biased DBA/2 mice. We also determined if impaired healing of bleomycin-induced injury would prolong fibrosis in the C57BL/6J mice. Endothelial nitric oxide (which protects endothelial cells from oxidant-induced injury) synthase knockout animals on a C57BL/6J background also had prolonged fibrosis, similar to DBA/2 mice, after multiple bleomycin exposures. This was specific to eNOS, as inducible nitric oxide synthase knockout animals cleared the fibrosis as effectively as wild-type C57BL/6J mice. This data indicate that healing of injury/fibrosis after bleomycin is complex and can be determined by a number of genetic and environmental factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676806     DOI: 10.1165/rcmb.2003-0029OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  41 in total

Review 1.  Reactive oxygen species as signaling molecules in the development of lung fibrosis.

Authors:  Francisco J Gonzalez-Gonzalez; Navdeep S Chandel; Manu Jain; G R Scott Budinger
Journal:  Transl Res       Date:  2017-10-10       Impact factor: 7.012

Review 2.  Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis.

Authors:  Christina E Barkauskas; Paul W Noble
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-16       Impact factor: 4.249

3.  Idiopathic pulmonary fibrosis: a disorder of epithelial cell dysfunction.

Authors:  Donald F Zoz; William E Lawson; Timothy S Blackwell
Journal:  Am J Med Sci       Date:  2011-06       Impact factor: 2.378

Review 4.  Progress toward improving animal models for idiopathic pulmonary fibrosis.

Authors:  Amber L Degryse; William E Lawson
Journal:  Am J Med Sci       Date:  2011-06       Impact factor: 2.378

Review 5.  Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation.

Authors:  Dongwei Gao; Sha Li
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

6.  Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.

Authors:  Jun Tashiro; Sharon J Elliot; David J Gerth; Xiaomei Xia; Simone Pereira-Simon; Rhea Choi; Paola Catanuto; Shahriar Shahzeidi; Rebecca L Toonkel; Rahil H Shah; Fadi El Salem; Marilyn K Glassberg
Journal:  Transl Res       Date:  2015-09-18       Impact factor: 7.012

7.  Magnetic resonance imaging of disease progression and resolution in a transgenic mouse model of pulmonary fibrosis.

Authors:  Zackary I Cleveland; Yu M Zhou; Teckla G Akinyi; R Scott Dunn; Cynthia R Davidson; Jinbang Guo; Jason C Woods; William D Hardie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-27       Impact factor: 5.464

8.  Genetic susceptibility to interstitial pulmonary fibrosis in mice induced by vanadium pentoxide (V2O5).

Authors:  Dianne M Walters; Kevin M White; Ushma Patel; Martin J Davis; Roberta M Veluci-Marlow; Solomon Raju Bhupanapadu Sunkesula; James C Bonner; Jessica R Martin; Wes Gladwell; Steven R Kleeberger
Journal:  FASEB J       Date:  2013-11-27       Impact factor: 5.191

9.  Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion.

Authors:  Rudolf K Braun; Jill M Koch; Timothy A Hacker; David Pegelow; Jaehyup Kim; Amish N Raval; Eric G Schmuck; Denise J Schwahn; Derek J Hei; John M Centanni; Marlowe Eldridge; Peiman Hematti
Journal:  Cytotherapy       Date:  2016-04       Impact factor: 5.414

10.  Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice.

Authors:  Varsha V Gupte; Suresh K Ramasamy; Raghava Reddy; Jooeun Lee; Paul H Weinreb; Shelia M Violette; Andreas Guenther; David Warburton; Barbara Driscoll; Parviz Minoo; Saverio Bellusci
Journal:  Am J Respir Crit Care Med       Date:  2009-06-04       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.